Connect your AI

Pacira BioSciences, Inc. PCRX Total Assets

Total Assets at other companies

Avanos MedicalAVNS

$1.05B-5.2%

Collegium Pharmaceutical, Inc.COLL

$1.65B+1.3%

AtriCureATRC

$643.99M+8.8%

Other financials

Income statement

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Cash flow

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

Market cap$942.78M-16.0%

Enterprise value$1.21B+1.2%

P/E183.5×—

P/S1.3×-0.3×

Profitability

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pacira BioSciences, Inc.'s total assets?: Pacira BioSciences, Inc. (PCRX) reported total assets of $1.21B in Q1 2026.
How has Pacira BioSciences, Inc.'s total assets changed year-over-year?: Pacira BioSciences, Inc.'s total assets decreased by 23.8% year-over-year, from $1.59B to $1.21B.
What is the long-term trend for Pacira BioSciences, Inc.'s total assets?: Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s total assets has grown at a -0.2% compound annual growth rate (CAGR), from $1.27B to $1.26B.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.